Good afternoon.  I am pleased to share with you that we are formally proceeding with our application to trade on the TSX Venture Exchange (“TSX-V”).  This process can take several weeks, and we will work closely with the team at the TSX-V to move through the requirements as quickly as possible.

Listing on the TSX-V is a great step for Mountain Valley MD and will provide increased liquidity and trading capabilities in MVMD’s common shares for both institutional and retail investors.  This is a significant part of our efforts to broaden our appeal to a larger shareholder base and continue to raise the Company’s profile among the North American investment community.  The TSX-V also provides stronger trading rule enforcement that is appropriate as MVMD matures, thus enhancing shareholder confidence in the fairness of the trading market.

In the meantime, MVMD’s shares will continue to trade on the Canadian Securities Exchange under the ticker symbol “MVMD”.  We will provide you with updates as they become available.

We are in a very exciting time for Mountain Valley MD and many of our key trial initiatives will be reporting important data in the very near future.  I look forward to sharing many updates and insights with you over the coming weeks, including some of our new projects, all which continue to advance our pursuit of redefining what is possible in global animal and human health.